Ltd Israeli-Georgian Medical Research Clinic Helsicore
Tbilisi 0112
0 studies enrolling now · 13 studies all time
What they study most
Advanced Breast Cancer, Breast Cancer, Chronic Gout, Follicular Lymphoma (FL), Glomerular Disease, Gout, Gout Flare, Hyperuricemia, Marginal Zone Lymphoma, Non Hodgkin Lymphoma, Proteinuria, Rheumatoid Arthritis
Studies at this site
- A Study of Lerociclib in Participants With Advanced Breast Cancer — Stopped early
- A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II — Completed
- Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients — Completed
- Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis — Completed
- Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL) — Stopped early
- Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC) — Completed
- A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC — Status unconfirmed
- Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis — Completed
- Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis — Completed
- Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease — Status unconfirmed
- Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate — Completed
- A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02). — Completed
- Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate — Completed